Hofseth Biocare and DKSH announce pan-Asian distribution deal

DKSH will distribute Hofseth Biocare products across China, India, Japan and South Korea.

Hofseth Biocare has sealed a distribution contract with DKSH for its marine-branded products. The agreement covers 10 territories across Asia, including Thailand, Indonesia, Philippines, Malaysia, Vietnam, China, Japan, South Korea, Taiwan and India. DKSH will also have the right to sell “white labelled” finished products across the territories on a non-exclusive basis.

The products included in the distribution agreement are ProGo Nutrition, a salmon protein hydrolysate; CollaGo Collagen Peptides, a soluble type 1 and 3 collagen peptide powder to help support healthy skin, muscles and arteries; CalGo Collagenic Hydroxyapatite, a collagen calcium powder; and OmeGo Unrefined Salmon Oil, which provides antioxidant and anti-inflammatory effects and is beneficial for maintaining healthy cholesterol and cardiovascular function.

Crawford Currie, head of medical R&D, Hofseth Biocare, said: “We believe there is a vast opportunity for our product in Asia given that the regional palate is typically very predisposed to eating fish and fish-derived products. Countries such as Malaysia and Indonesia have amongst the highest consumption of fish per capita in the world.

“It is no co-incidence that these countries have very low levels of heart disease and asthma, where our products unsurprisingly show significant health benefits too. Furthermore, our Bioactive peptides will be a better alternative for millions of people who struggle with negative side effects or poor effect of traditional iron supplementation.”

The distribution contract with DKSH follows soon after granting a set of label claims for ProGo in North America, centred around the prevention of iron deficiency anaemia. Bioactive Peptides are in the position of being the “first and only non-iron containing product” in the US market to maintain healthy levels of ferritin and haemoglobin. It is also a part of a strategy to empower global distributors to lever the Hofseth Biocare science and ingredients to penetrate the business-to-business segment on a worldwide basis.